Xilio Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $60.9M
Liabilities Breakdown FY2023
Total Liabilities: $24.1M
Asset Breakdown
Total Assets: $60.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $44.7M | 73.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.9M | 9.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $10.3M | 16.9% |
Liabilities Breakdown
Total Liabilities: $24.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 4.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $23.0M | 95.6% |